Success Metrics

Clinical Success Rate
87.1%

Based on 135 completed trials

Completion Rate
87%(135/155)
Active Trials
10(5%)
Results Posted
37%(50 trials)
Terminated
20(10%)

Phase Distribution

Ph phase_2
49
24%
Ph phase_1
36
18%
Ph not_applicable
20
10%
Ph early_phase_1
9
4%
Ph phase_3
29
14%
Ph phase_4
54
26%

Phase Distribution

45

Early Stage

49

Mid Stage

83

Late Stage

Phase Distribution197 total trials
Early Phase 1First-in-human
9(4.6%)
Phase 1Safety & dosage
36(18.3%)
Phase 2Efficacy & side effects
49(24.9%)
Phase 3Large-scale testing
29(14.7%)
Phase 4Post-market surveillance
54(27.4%)
N/ANon-phased studies
20(10.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.8%

135 of 167 finished

Non-Completion Rate

19.2%

32 ended early

Currently Active

10

trials recruiting

Total Trials

205

all time

Status Distribution
Active(13)
Completed(135)
Terminated(32)
Other(25)

Detailed Status

Completed135
unknown25
Terminated20
Withdrawn12
Recruiting6
Active, not recruiting4

Development Timeline

Analytics

Development Status

Total Trials
205
Active
10
Success Rate
87.1%
Most Advanced
Phase 4

Trials by Phase

Early Phase 19 (4.6%)
Phase 136 (18.3%)
Phase 249 (24.9%)
Phase 329 (14.7%)
Phase 454 (27.4%)
N/A20 (10.2%)

Trials by Status

withdrawn126%
unknown2512%
not_yet_recruiting31%
active_not_recruiting42%
completed13566%
recruiting63%
terminated2010%

Recent Activity

Clinical Trials (205)

Showing 20 of 205 trialsScroll for more
NCT03142568Phase 2

Safety of Sildenafil in Premature Infants

Completed
NCT07039760Early Phase 1

Asciminib With or Without Sildenafil for Brain Tumors

Not Yet Recruiting
NCT06123156Phase 3

Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer

Not Yet Recruiting
NCT04447989Phase 2

Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia

Completed
NCT06510322Early Phase 1

Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support

Recruiting
NCT06954597Phase 2

Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis

Recruiting
NCT04481789Phase 1

Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study)

Completed
NCT03855332Phase 2

Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial

Completed
NCT06800092Phase 2

Sildenafil to Prevent and Reduce Cancer Related Cognitive Impairment

Not Yet Recruiting
NCT04797286Phase 2

Sildenafil for Early Pulmonary Vascular Disease in Scleroderma

Recruiting
NCT05765487Phase 1

Using Thermography to Assess the Affects of Sildenafil Cream, 3.6%

Completed
NCT06778330Not Applicable

The Effect of Combination of Dapagliflozin and Sildenafil in Treatment of Heart Failure Patients With Secondary Pulmonary Hypertension

Completed
NCT04356716Phase 2

Sildenafil for Treatment of Choroidal Ischemia

Completed
NCT03686306Phase 3

VIRTUOSE : Efficiency of Sildenafil on the Absolute Claudication Distance of Peripheral Arterial Disease Patients With Intermittent Claudication.

Active Not Recruiting
NCT02983461Phase 1

Use of Sildenafil for Treatment of Urinary Incontinence

Active Not Recruiting
NCT02682147Phase 4

Functional CT Assessment of Pulmonary Arterial Dysfunction in Smoking Associated Emphysema

Active Not Recruiting
NCT04211272Phase 1

A 2-part Study to Investigate the Effect of Macitentan in Healthy Male Participants

Completed
NCT04538976Phase 4

Copd Exacerbation and Pulmonary Hypertension Trial

Completed
NCT06875258Phase 4

PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)

Recruiting
NCT06860399Phase 1

Vardenafil Vs Sildenafil for the Treatment of Pulmonary Hypertension of the Newborn

Completed

Drug Details

Intervention Type
DRUG
Total Trials
205